Football Players Health Study In Person Assessments Study

NCT ID: NCT03866564

Last Updated: 2024-05-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

111 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-04-22

Study Completion Date

2022-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the Football Players Health Study (FPHS) is to advance the understanding of the complex and inter-related pathways that can develop into player related illness and disability. Former National Football League players will be given the opportunity to undergo 2\&1/2 days of rigorous assessment in the areas of Cardiac Dysfunction, Neurocognitive Disease, Chronic Pain, and Sleep Apnea to attempt to define the pathology among former professional athletes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Little is known about the long term health impacts of being exposed to a career in professional football. The primary objective of this study is to assess the relationship between affliction definitions, as subjectively described by participants in the first phase of the study (Q1), and objective pathology as defined by standard of care clinical and investigational testing. An exploratory secondary objective of this study is to examine the relationships between exposure to football, defined within the parameters of how old was the participant when their career started, how long did they play professional football, what was the participants field position and objective pathology defined as standard of clinical care.

The questions the study hopes to answer are as follows: 1) Are subjective complaints among former professional football players associated with objective evidence of pathology as measured by clinically accepted diagnostic testing (Primary objective), and 2) Is exposure to professional football, as defined by variables including career duration and player field position, associated with cardiac dysfunction, neurocognitive disease, chronic pain, and sleep apnea (Secondary objective).

This protocol has been constructed with an emphasis on reducing risk and maximizing yield. The Investigators who will be performing the assessments across the Harvard Medical School Institutions have worked together to minimize potential risk exposure by carefully selecting imaging protocols that limit radiation exposure, keeping phlebotomy limited, and by conducting these assessments under the supervision of investigators with established track records for conducting safe and effective human subject research.

The study visit will occur over 2\&1/2 days. All costs of transportation, lodging, and meals will be covered by the study. All participants will have the assistance of a Study Navigator, a member of the FPHS staff who will accompany the participant. This navigator will assure that the participant gets to each assessment, helps to make decisions regarding scheduling issues or conflicts, assesses the need for additional breaks, and acts as a resource and guide for the participant throughout the study. The navigator will be in communication with key members of the research team for real time decision making (aborting or skipping an assessment).

Participants will be advised that results from these assessments are research results and are not meant for any diagnosis of disease. However, assessment results will be given to the participant if they wish to receive them. Any incidental finding that may have clinical relevance will be explained by a Study Physician and the Medical Navigation Nurse, and the participant will be assisted in obtaining follow up care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Dysfunction Neurocognitive Disease Chronic Pain Sleep Apnea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Multi-Afflicted

Participants with multiple self reported afflictions will undergo comprehensive research health screenings including Echocardiography (to define cardiac dysfunction), Neuropsychological Testing (to define neurocognitive disease), Pain Catastrophizing Scale (to define chronic pain), and Nocturnal Polysomnography (to define sleep apnea).

Echocardiography

Intervention Type DIAGNOSTIC_TEST

Cardiac ultrasound to measure left ventricular systolic function.

Neuropsychological Testing

Intervention Type DIAGNOSTIC_TEST

Standard clinical testing designed to establish or exclude the presence of cognitive dysfunction.

Quantitative Sensory Testing

Intervention Type DIAGNOSTIC_TEST

Clinically accepted quantitative assessment of chronic pain burden.

Nocturnal Polysomnography

Intervention Type DIAGNOSTIC_TEST

Routine overnight sleep study to measure apnea-hypopnea index.

Un-Afflicted

Participants who report no afflictions will undergo comprehensive research health screenings including Echocardiography (to define cardiac dysfunction), Neuropsychological Testing (to define neurocognitive disease), Pain Catastrophizing Scale (to define chronic pain), and Nocturnal Polysomnography (to define sleep apnea).

Echocardiography

Intervention Type DIAGNOSTIC_TEST

Cardiac ultrasound to measure left ventricular systolic function.

Neuropsychological Testing

Intervention Type DIAGNOSTIC_TEST

Standard clinical testing designed to establish or exclude the presence of cognitive dysfunction.

Quantitative Sensory Testing

Intervention Type DIAGNOSTIC_TEST

Clinically accepted quantitative assessment of chronic pain burden.

Nocturnal Polysomnography

Intervention Type DIAGNOSTIC_TEST

Routine overnight sleep study to measure apnea-hypopnea index.

Single Afflicted

Participants with one self reported afflictions will undergo comprehensive research health screenings including Echocardiography (to define cardiac dysfunction), Neuropsychological Testing (to define neurocognitive disease), Pain Catastrophizing Scale (to define chronic pain), and Nocturnal Polysomnography (to define sleep apnea).

Echocardiography

Intervention Type DIAGNOSTIC_TEST

Cardiac ultrasound to measure left ventricular systolic function.

Neuropsychological Testing

Intervention Type DIAGNOSTIC_TEST

Standard clinical testing designed to establish or exclude the presence of cognitive dysfunction.

Quantitative Sensory Testing

Intervention Type DIAGNOSTIC_TEST

Clinically accepted quantitative assessment of chronic pain burden.

Nocturnal Polysomnography

Intervention Type DIAGNOSTIC_TEST

Routine overnight sleep study to measure apnea-hypopnea index.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Echocardiography

Cardiac ultrasound to measure left ventricular systolic function.

Intervention Type DIAGNOSTIC_TEST

Neuropsychological Testing

Standard clinical testing designed to establish or exclude the presence of cognitive dysfunction.

Intervention Type DIAGNOSTIC_TEST

Quantitative Sensory Testing

Clinically accepted quantitative assessment of chronic pain burden.

Intervention Type DIAGNOSTIC_TEST

Nocturnal Polysomnography

Routine overnight sleep study to measure apnea-hypopnea index.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 24-55 at the time of first Health and Wellness Questionnaire (Q1) completion.
* Former professional football player who played between 1960 to present.
* Prior completed the first Health and Wellness Questionnaire (Q1)
* "Healthy" subjects: ability to give informed consent and comply with study procedures.
* "Afflicted" participants: must meet criteria for at least one of the following subjective afflictions based on Q1 responses: 1) Cardiovascular Dysfunction, 2) Neurocognitive Disease, 3) Chronic Pain, and/or 4) Sleep Apnea

Exclusion Criteria

* Prior metallic device implants such as cardiac pacemakers/defibrillators or perfusion pumps that cannot be removed.
* Ferromagnetic implants or objects that cannot be removed such as aneurysm clips, surgical clips, prostheses, artificial hearts, valves with steel parts, metal fragments, shrapnel, tattoos near the eye, or steel implants or jewelry
* Body weight \>390 lbs at screening
* Inability to complete the telephone screener
* Low T-MoCA score (\<17) and absence of an available study partner if required following MD review.
* Significant behavioral or functional disability due to cognitive impairment
Minimum Eligible Age

24 Years

Maximum Eligible Age

55 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Harvard Medical School (HMS and HSDM)

OTHER

Sponsor Role collaborator

Beth Israel Deaconess Medical Center

OTHER

Sponsor Role collaborator

Martinos Center for Biomedical Imaging

OTHER

Sponsor Role collaborator

Brigham and Women's Hospital

OTHER

Sponsor Role collaborator

Massachusetts General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Meagan Murphy Wasfy

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Meagan M Wasfy, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

Massachusetts General Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Massachusetts General Hospital

Boston, Massachusetts, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2018P001929

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.